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Purpose: Mutations in IDH3B, an enzyme participating in the Krebs cycle, have recently been found to cause autosomal
recessive retinitis pigmentosa (arRP). The  MDH1 gene maps within the  RP28 arRP linkage interval and encodes
cytoplasmic malate dehydrogenase, an enzyme functionally related to IDH3B. As a proof of concept for candidate gene
screening to be routinely performed by ultra high throughput sequencing (UHTs), we analyzed MDH1 in a patient from
each of the two families described so far to show linkage between arRP and RP28.
Methods: With genomic long-range PCR, we amplified all introns and exons of the MDH1 gene (23.4 kb). PCR products
were then sequenced by short-read UHTs with no further processing. Computer-based mapping of the reads and mutation
detection were performed by three independent software packages.
Results: Despite the intrinsic complexity of human genome sequences, reads were easily mapped and analyzed, and all
algorithms used provided the same results. The two patients were homozygous for all DNA variants identified in the
region, which confirms previous linkage and homozygosity mapping results, but had different haplotypes, indicating
genetic or allelic heterogeneity. None of the DNA changes detected could be associated with the disease.
Conclusions: The MDH1 gene is not the cause of RP28-linked arRP. Our experimental strategy shows that long-range
genomic PCR followed by UHTs provides an excellent system to perform a thorough screening of candidate genes for
hereditary retinal degeneration.
Retinitis pigmentosa (RP; OMIM 268000) is a hereditary
and  progressive  form  of  retinal  degeneration,  with  an
estimated  prevalence  of  one  patient  in  4,000  people  [1].
Affected individuals experience the constant and unstoppable
death  of  photoreceptors,  a  phenomenon  that  results  in
increasing  loss  of  sight  and  in  many  instances  legal  or
complete  blindness  [2].  Genetically,  RP  is  a  highly
heterogeneous condition, since around 50 genes or loci, most
of  which  act  as  individual  Mendelian  entities,  have  been
implicated so far (RetNet).
The RP28 locus associated with autosomal recessive RP
(arRP) has previously been mapped to chromosome 2p14-p15
through the analyses of two consanguineous but apparently
unrelated Indian families [3,4]. The candidate region spans
1.06 cM and includes 15 genes, 14 of which are expressed in
the retina. None of these genes has been previously associated
with  retinal  degeneration  or  is  known  to  have  a  specific
function in the retina. The IDH3B gene, which encodes for the
β subunit of isocitrate dehydrogenase 3 (NAD+ dependent,
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EC 1.1.1.41), was recently found to be associated with arRP,
indicating a link between the Krebs cycle and retinal disease
[5].  One  of  the  genes  within  the  RP28  linkage  interval,
MDH1,  encodes  for  the  cytosolic  form  of  malate
dehydrogenase (EC 1.1.1.37), which is directly connected to
the Krebs cycle via the malate-aspartate shuttle. The gene
products of IDH3B and MDH1 are related at an additional
functional level, since malate dehydrogenase can convert the
product of isocitrate dehydrogenase [6] (Figure 1). Therefore,
we reasoned that MDH1 could correspond to the RP28 locus,
and mutations in its sequence could be responsible for the
disease in a manner similar to that of pathogenic changes in
IDH3B.
A  common  approach  to  the  mutational  screening  of
candidate  genes  consists  of  sequencing  their  exons  and
immediate  intron  boundaries.  However,  since  pathogenic
mutations can sometimes be located deep within introns, as
was recently shown for retinal degeneration genes as well
[7,8], we decided to analyze the full MDH1 sequence. To
circumvent  problems  linked  to  sequence  length  and
composition and to test the potential of parallel sequencing in
routine mutation detection, we used long-range PCR (LR-
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2627PCR) amplification of genomic DNA followed by ultra high
throughput sequencing (UHTs).
METHODS
DNA samples and long-range PCR: The genomic DNA used
in  this  study  was  part  of  the  collection  of  samples  that
originally allowed mapping of the RP28 locus. Samples were
obtained in accordance with the ethical guidelines regulating
these  previous  investigations  [3,4].  Specifically,  they
belonged to patient V-4 from family PMK146 [3] and patient
IV-7 from family IIS-2 [4]. The entire MDH1 gene (nine exons
and eight introns) as well as an additional 0.5 kb upstream and
4.7  kb  downstream  (23,459  bp  in  total,  from  nucleotide
63,669,094 to nucleotide 63,692,552 of chromosome 2, NCBI
Homo sapiens Build 36.3, NC_000002.10) were amplified by
three tiled LR-PCRs, using the primer pairs described in Table
1. PCR reaction mixes were set as specified by the standard
protocol of TaKaRa LA Taq (TaKaRa Bio Inc., Shiga, Japan)
using  GC  Buffer  I,  except  the  final  reaction  volume  was
reduced to 10 µl, and the concentration of each primer to
0.1 µM. The thermal profile common to all sets of primers
consisted of an initial step at 94 °C for 1 min, followed by 30
Figure 1. Schematic representation of the Krebs cycle. The specific
functions  of  two  enzymes,  isocitrate  dehydrogenase  (NAD+
dependent, partly encoded by IDH3) and the MDH1-encoded malate
dehydrogenase, are shown.
cycles at 98 °C for 5 s and 68 °C for 15 min, and a final step
at 72 °C for 10 min. Prior to sequencing, LR-PCR products
were checked on agarose gel, quantified using the ImageJ
software [9], and pooled in roughly equimolar quantities.
Ultra  high  throughput  (UHT)  and  conventional  Sanger
sequencing: UHTs was performed with an Illumina Genome
Analyzer (Illumina, San Diego, CA) for the DNA of patient
IV-7/IIS-2 and an Illumina Genome Analyzer II (Illumina)
with the paired-end procedure for the DNA of patient V-4/
PMK146,  according  to  the  manufacturer’s  protocols  and
starting from around 400 ng of LR-PCR products.
Conventional Sanger sequencing was performed using
exon-specific primers (Table 2) and the BigDye Terminator
v1.1 cycle sequencing kit (Applied Biosystems, Foster City,
CA)  on  LR-PCR  products  purified  by  treatment  with
ExoSAP-IT  (USB,  Cleveland,  OH).  Sequencing  reactions
were purified on Performa DTR columns (Edge BioSystems,
Gaithersburg,  MD)  and  run  on  an  ABI-3130XL  (Applied
Biosystems).
Sequence analysis: Mapping and analysis of UHTs reads were
performed  independently  with  the  use  of  three  different
software packages: FetchGWI/align0 [10,11], Maq [12], and
the CLC Genomics Workbench (CLC bio, Aarhus, Denmark).
In all instances, analyses were performed on the original calls
generated by the Genome Analyzer. The procedure followed
when using the FetchGWI/align0 packages was composed of
multiple sequential steps. First, all the reads were filtered
according  to  the  Phred  quality  score  of  each  nucleotide,
replacing nucleotides with low scores by “Ns” and discarding
reads with more than three Ns. Second, fetchGWI was used
to find unique exact matches of all the retained reads. Reads
that mapped within the target regions were directly used,
while those mapping outside of these regions were kept as a
negative control group. Third, among reads for which it was
impossible to find any matches (either unique or repeated),
those  sharing  a  common  12-mer  (except  mono-  or  di-
nucleotide repeats) with the selected regions were kept and
aligned against them by a global Smith-Waterman procedure
(by align0). Fourth, reads that had a good score (no more than
three  mismatches)  were  verified  not  to  produce  a  better
alignment score against the negative control group kept during
the  first  step.  Finally,  DNA  variants  were  derived  from
TABLE 1. PRIMER PAIRS USED IN LR-PCRS.
Nucleotide sequence (5′-3′) Size of PCR product (bp)
F: TGTCCGGTCGTCCCAACTTATCAATTC 11,429
R: CTGGTCACTGGCTCCTTGGCATACTTATCTAT
F: CAAGGAGAACTTCAGTTGCTTGACTCGTTT 6,752
R: AACACCATAGGAGTTGCCATCAGAGATAACAC
F: TGAGGATTAGGTTTCCCTGGCCTACTTCAC 6,204
R: TCAATTGTGCTACCCAGGTCAGGCTATGA
Abbreviations: F represents forward primer; R represents reverse primer.
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2628sequences retained at step #1 and from the global alignment
outputs  produced  at  step  #3.  Mapping  of  sequences  and
mutation detection via Maq were accomplished as follows.
First, Maq performed ungapped alignments of the reads on the
reference sequence by retaining only reads with one or no
mismatches  in  the  first  24  bases  and  a  maximum  of  one
mismatch  for  the  remaining  bases.  After  mapping,  Maq
generated  a  consensus  sequence  and  calculated  the  Phred
quality score at each position of this sequence. Results from
the  analysis  allowed  the  calling  of  genomic  variations
compared to reference sequence. The requirements for calling
a variation were a minimum Phred quality score of 40; no
insertions or deletions in the range of five bases; only an
additional single nucleotide polymorphism (SNP) within a
ten-base window; a minimum neighbor Phred quality score of
20; and a minimum coverage of 3×. The CLC Genomics
Workbench-assisted mapping and mutation detection were
conducted according to the general procedure recommended
by the software house. More specifically, the raw sequences
first underwent a filtering and trimming process based on the
quality of their scores (quality score cutoff=0.01, maximum
number of ambiguous nucleotides=2). All reads satisfying
these criteria were then mapped on the 23,459-bp reference
sequence mentioned above using the Reference Assembly
algorithm  within  the  UHTs  module  of  the  CLC  package
(mismatch cost=2, indel costs=3). Detection of variants was
performed by identifying on the final mapping all bases for
which 60% or more of the calls differed from the reference
sequence, regardless of the base coverage.
Electropherograms generated by Sanger sequencing were
analyzed either by the Staden software package [13] or the
CLC Genomics Workbench (CLC bio).
RESULTS
We sequenced 23,459 bp of human chromosome 2, which
span the MDH1 gene, in patients V-4/PMK146 and IV-7/IIS-2
by UHTs. All three software packages used to filter and align
the reads provided essentially the same results and identified
the same DNA variants, all of which were intronic (Table 3).
As expected, affected members from the two consanguineous
families displayed homozygosity for all DNA changes present
in the region. This supports the hypothesis that two copies of
the same recessive mutation were inherited by patients from
a single ancestor who was common to both their paternal and
maternal branches, as previous microsatellite analyses have
suggested [3,4]. Since all of the identified variants represented
either known SNPs or changes with no predicted effects on
splicing  [14],  none  of  them  was  considered  potentially
pathogenic. Sanger sequencing of all MDH1 exons and their
intron vicinities confirmed the absence of DNA variants with
respect to the reference sequence, apart from seven SNPs
already  detected  by  UHTs:  rs10469944,  rs2305157,
rs7606045,  rs2604613,  rs262472,  rs262473  (in  V-4/
PMK146) and g.42648177T>A (in IV-7/IIS-2).
The large majority of UHTs reads were of good quality,
as only a minimal part of them were discarded by the filtering
procedures. Furthermore, filtered sequences could be easily
mapped back to the reference sequence of the human genome,
with an overall success rate of about 97%. The average length
of the reads (30.5 bases) was also satisfying and, given the
amount of sequences that were generated, produced a very
high mean base coverage. More specifically, sequencing runs
produced 5.2 million and 4.8 million raw sequences when the
LR-PCRs  from  patients  V-4/PMK146  and  IV-7/IIS-2,
respectively, were used as a template. Following the Maq
procedure, 5.1 million and 4.5 million sequences from these
two  samples  were  retained  after  filtering  for  quality,
generating an average coverage of 7,600× and 6,700× per
given base. Slightly lower values were obtained with the CLC
bio and FetchGWI/align0 packages. For CLC bio, 4.9 million
(V-4/PMK146) and 3.8 million (IV-7/IIS-2) reads from the
raw  sequences  satisfied  filtering  criteria,  producing  an
average coverage of 7,000× and 4,700×, respectively. For the
FetchGWI/align0 procedure, the corresponding values were
5.0 million and 3.1 million sequences, resulting in a mean
coverage of 6,500× and 3,700×.
To determine the limits of UHTs as a potential tool for
routine  mutation  detection  in  a  homozygous  context,  we
simulated  various  coverage  values  by  randomly  selecting
500,000, 50,000, 25,000, 10,000, and 5,000 filtered reads
from the V-4/PMK146 sample. We then remapped them onto
the 23,459-bp reference contig with the CLC bio software,
exactly  as  performed  on  the  original  set  of  sequences.
Although the average coverage was substantially different
TABLE 2. PRIMERS USED IN SANGER SEQUENCING.
Nucleotide sequence (5′-3′) Exon
GCTCATCCTCAGGGACTACTTTGCAATC 1
CCAGGGTTTGGATCACCACATACTGAAC 2
GTGGTGATTCCTCTCACTGTGTCTGTTAGC 3
CTCAGGCTCCTGAAATGTATATCAGTGTG 4
ATCAAGTAGGAAGTCCAGCCTCT 5
GTCCACAGTTGTTACCACTGTTAAGCTG 6
GCCAGTCATGATCTAGTGTGATCTGATGTG 7
CCTGGTGCTGATGATAGTTCCTTACACA 8
GTAGAGATGGGGTGTCACTATTTG 9
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2629across  the  sets,  as  well  as  proportional  to  the  simulated
coverage (Table 4), we did not observe any dramatic reduction
in  power  for  the  correct  detection  of  SNPs.  Specifically,
whenever coverage of at least 2× could be preserved, all SNPs
were correctly called (Table 4). Below this threshold, false
positives  began  to  appear,  as  expected,  since  technical
sequencing errors could not be verified by any overlapping
sequence (data not shown).
DISCUSSION
Identification of RP genes can be performed via genome-wide
linkage analyses (when large families with multiple affected
individuals are available), candidate gene screenings (when
several dozen unrelated patients can be investigated), or a
combination of both techniques. Good candidate genes share
sequence similarities with other disease genes, relate to the
same  biochemical  pathway,  or  are  expressed  mainly  or
exclusively in the affected tissue or organ [15,16]. To increase
the chances of gene identification, the systematic screening of
all  genes  present  within  an  interval  defined  by  linkage
mapping has also been adopted, allowing the discovery of
mutations in genes that, a priori, were not considered prime
candidates [17,18].
Regardless of the strategy used to select the candidate
genes,  in  most  cases   only  exonic  and  nearby  intronic
sequences  are  investigated,  for  a  few  practical  reasons.
Specifically, exons and surrounding splicing signals are more
likely to harbor disease-causing mutations than deep intronic
regions. In addition, they are shorter and cheaper to analyze
as well as easier to sequence, since they rarely contain repeats
or  low-complexity  regions.  However,  by  definition,  this
strategy prevents the identification of deep intronic mutations.
In this study, we perform a mutational screening on a
candidate  gene  that  maps  within  a  previously  identified
linkage interval by using UHTs to analyze its introns and
exons. We exclude MDH1 as a candidate gene for RP28-
linked arRP and determine that patients from the only RP28
families identified so far carry different haplotypes in this
region. Under the assumption that the disease is caused by an
RP28 mutation in both families, our finding suggests that
these Indian pedigrees are truly unrelated. The absence of a
common disease haplotype implies the absence of a founder
mutation and, furthermore, does not exclude the possibility
that two distinct arRP loci could lie in this region. Therefore,
the 13 other genes present in the RP28 interval and expressed
in the retina remain to be screened, likely by a global and blind
TABLE 3. VARIANTS DETECTED IN PATIENTS V-4/PMK146 AND IV7/IIS-2.
Patient Variant # dbSNP entry HGVS name (position)
V-4/PMK146 1 rs10469944 NT_022184.14:g.42632605C>G
2 rs10469945 NT_022184.14:g.42632709T>C
3 rs6546018 NT_022184.14:g.42633355G>T
4 rs6546019 NT_022184.14:g.42633373A>G
5 rs1446569 NT_022184.14:g.42634247C>G
6 rs4671519 NT_022184.14:g.42636331C>T
7 rs2305157 NT_022184.14:g.42638718T>C
8 rs10865340 NT_022184.14:g.42639982C>G
9 rs10865341 NT_022184.14:g.42639983A>T
10 rs11125979 NT_022184.14:g.42640239T>G
11 rs4671069 NT_022184.14:g.42641337C>A
12 rs1255 NT_022184.14:g.42641867T>C
13 rs7606045 NT_022184.14:g.42642461T>G
14 rs964880 NT_022184.14:g.42642865C>A
15 rs2121351 NT_022184.14:g.42644294G>A
16 rs262470 NT_022184.14:g.42646492C>T
17 rs262471 NT_022184.14:g.42646802G>A
18 rs2604613 NT_022184.14:g.42648709G>A
19 rs262472 NT_022184.14:g.42649549G>A
20 rs262473 NT_022184.14:g.42649746G>T
21 rs262474 NT_022184.14:g.42650552A>G
22 rs262489 NT_022184.14:g.42652200G>A
23 rs262490 NT_022184.14:g.42653584A>G
IV-7/IIS-2 1 NR NT_022184.14:g.42645344C>G
2 NR NT_022184.14:g.42648177T>A
NR, not referenced in public databases.
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2630sequencing  strategy.  Unlike  MDH1,  no  biologic  feature
currently points to another promising candidate. Since several
genes have already been shown to cause RP despite their
apparent irrelevance to retinal physiology as well as their
ubiquitous  expression,  the  hypothesis  that  a  non-obvious
candidate  could  be  the  RP28  gene  is  not  particularly
surprising.
However, in addition to these specific results, our work
can be considered a proof of concept experiment for the use
of  highly  parallel  sequencing  techniques  for  mutation
detection in monogenic diseases. The assumption that UHTs
could  replace  conventional  sequencing  in  human  gene
screening procedures is not completely straightforward, since
the former technique has a series of defects (e.g., short read
length and relatively poor accuracy in base calling) that render
it  not  particularly  suitable  for  the  analysis  of  the  human
genome  [19].  Although  we  have  willingly  reduced  the
complexity of our analyses by selecting homozygous DNA
regions in patients from consanguineous families, our results
indicate that mutation detection via UHTs could be performed
even  when  coverage  is  relatively  low.  Factors  such  as
heterozygozity  (e.g.,  in  dominant  diseases)  or  pooling  of
multiple  samples  unquestionably  increase  the  noise  and
decrease  the  power  of  UHTs  analyses.  However,  recent
studies have shown that, when specific countermeasures are
adopted,  these  confounding  elements  can  be  reduced  or
eliminated [20-22].
In summary, we believe that the strategy used for the
analysis  of  the  MDH1  gene  likely  represents  one  of  the
technical approaches to future candidate gene screening in
monogenic conditions. Since retinitis pigmentosa and allied
diseases show great genetic heterogeneity, the screening of
large sets of patient DNA samples is required. Therefore,
UHTs,  in  combination  with  systematic  long-range  PCR
[23-25]  or  genomic  sequence  capturing  [26,27],  can  be
particularly relevant in the analysis of this disorder.
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Calls in patient V-4/PMK146 (absolute coverage of the base)
SNP Reference
base
4,000,000
sequences
500,000
sequences
50,000
sequences
25,000
sequences
10,000
sequences
5,000
sequences
rs10469944 C G (3,901) G (332) G (34) G (22) G (7) G (2)
rs10469945 T C (3,602) C (375) C (35) C (22) C (6) C (4)
rs6546018 G T (3,445) T (315) T (30) T (18) T (8) T (5)
rs6546019 A G (3,403) G (316) G (24) G (13) G (5) G (4)
rs1446569 C G (3,407) G (327) G (36) G (9) G (5) G (2)
rs4671519 C T (4,079) T (375) T (35) T (15) T (6) T (4)
rs2305157 T C (2,671) C (267) C (28) C (11) No Call No Call
rs10865340 C G (2,227) G (221) G (27) G (11) G (3) G (2)
rs10865341 A T (2,228) T (221) T (27) T (11) T (3) T (2)
rs11125979 T G (1,899) G (172) G (10) G (9) G (2) No Call
rs4671069 C A (3,053) A (275) A (27) A (14) A (7) No Call
rs1255 T C (2,588) C (249) C (25) C (15) C (5) No Call
rs7606045 T G (2,390) G (227) G (19) G (13) G (8) G (2)
rs964880 C A (5,158) A (480) A (52) A (24) A (12) A (7)
rs2121351 G A (6,998) A (684) A (51) A (29) A (14) A (7)
rs262470 C T (6,461) T (620) T (60) T (29) T (13) T (5)
rs262471 G A (6,379) A (545) A (56) A (31) A (13) A (6)
rs2604613 G A (5,445) A (514) A (69) A (32) A (9) A (4)
rs262472 G A (7,326) A (732) A (70) A (35) A (12) A (6)
rs262473 G T (3,401) T (308) T (33) T (13) T (7) T (3)
rs262474 A G (7,445) G (635) G (51) G (35) G (20) G (5)
rs262489 G A (6,908) A (528) A (47) A (33) A (9) A (6)
rs262490 A G (4,928) G (469) G (39) G (16) G (9) G (2)
W.S. Avg. Cov. 7,053 659 64.5 32.4 12.8 6.3
SNP Avg. Cov. 4,319 399 38.5 20 8.3 4.1
No Call, base call not performed (coverage<2); W.S. Avg. Cov., average base coverage for the whole sequence; SNP Avg. Cov.,
average base coverage of all detected SNPs.
Molecular Vision 2009; 15:2627-2633 <http://www.molvis.org/molvis/v15/a280> © 2009 Molecular Vision
2631
TABLE 4. VARIANTS DETECTED IN PATIENT V-4/PMK146 AS A FUNCTION OF BASE COVERAGE.(grant  #  320030–121929)  and  the  CEC  (EVI-GENORET
LSHG-CT-2005–512036).
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